MedTrace Logo

Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP

NCT03296670 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2020-03-12

No results posted yet for this study

Summary

The study intends to evaluate the efficacy of different medicine delivering by targeted perfusion catheter in coronary administration on coronary blood flow in STEMI patients with CSFP.

Conditions

  • ST Segment Elevation Myocardial Infarction
  • Coronary Slow Flow Phenomenon

Interventions

DRUG

Alprostadil

alprostadil,2ug, delivered by targeted perfusion catheter in the culprit vessel after PCI in STEMI patients with CSFP

DRUG

Nitroglycerin

Nitroglycerin,200ug, delivered by targeted perfusion catheter in the culprit vessel after PCI in STEMI patients with CSFP

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Ben He, MD,PhD · Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-01
Primary Completion
2017-04-28
Completion
2017-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03296670 on ClinicalTrials.gov